Takahiro Akahori

Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer

Takeo Nomi, Masayuki Sho, Takahiro Akahori et al. · Clinical Cancer Research · 2007 · 897 citations

Medicine, Immunology, Oncology +17

Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer

Satoshi Nishiwada, Masayuki Sho, Satoshi Yasuda et al. · Journal of Experimental & Clinical Cancer Research · 2015 · 180 citations · Full text

Medicine, Cancer Biology, Oncology +12

Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study

Ippei Matsumoto, Yoshiaki Murakami, Makoto Shinzeki et al. · Pancreatology · 2015 · 157 citations

Medicine, Oncology, Surgery +16

Clinical significance of CD155 expression in human pancreatic cancer.

Satoshi Nishiwada, Masayuki Sho, Satoshi Yasuda et al. · PubMed · 2015 · 143 citations

Medicine, Immunology, Oncology +15

Direct targeting of fibroblast growth factor-inducible 14 protein protects against renal ischemia reperfusion injury

Kiyohiko Hotta, Masayuki Sho, Ichiro Yamato et al. · Kidney International · 2010 · 85 citations · Full text

Medicine, Molecular Medicine, Nephrology +12